Voyager Therapeutics

-$0.30 (-6.82%) Today
+$0.03 (+0.73%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VYGR and other ETFs, options, and stocks.

About VYGR

Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01.

CEO
Michael J. Higgins
Employees
179
Headquarters
Cambridge, Massachusetts
Founded
2013

VYGR Key Statistics

Market Cap
155.54M
Price-Earnings Ratio
8.79
Dividend Yield
—
Average Volume
32.12M
High Today
$4.34
Low Today
$4.07
Open Price
$4.34
Volume
3.05M
52 Week High
$12.65
52 Week Low
$2.46

VYGR Earnings

-$0.80
$0.22
$1.25
$2.27
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 8, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure